CASI Pharmaceuticals CASI reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
CASI Pharmaceuticals beat estimated earnings by 12.5%, reporting an EPS of $-0.56 versus an estimate of $-0.64.
Revenue was up $1.41 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.3 which was followed by a 11.66% increase in the share price the next day.
Here's a look at CASI Pharmaceuticals's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.9 | -0.6 | -0.5 | -0.7 |
EPS Actual | -0.6 | -0.4 | -0.7 | -0.5 |
Revenue Estimate | 9.23M | 9.07M | 7.54M | 6.02M |
Revenue Actual | 9.06M | 9.16M | 8.11M | 7.16M |
To track all earnings releases for CASI Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.